Ignite Creation Date:
2024-07-17 @ 10:41 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06482073
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-06-25
Brief Title:
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care Interception for Suspected Lung Cancer
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care Interception for Suspected Lung Cancer
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates the effectiveness of robotic biopsies in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies
Detailed Description:
PRIMARY OBJECTIVES
I Assessing whether the percentage of samples adequate for WES Whole Exome SequencingWT Wild-Type sequencing is at least 80
II Development of a data bank of WESWT and germline sequencing data for future analyses
OUTLINE This is an observational study
Patients receive genomic counseling and genomic testing education undergo blood or saliva collection provide previously collected tissue sample and have medical records reviewed on study Patients and healthcare providers receive results of any genetic variants found on testing
I Assessing whether the percentage of samples adequate for WES Whole Exome SequencingWT Wild-Type sequencing is at least 80
II Development of a data bank of WESWT and germline sequencing data for future analyses
OUTLINE This is an observational study
Patients receive genomic counseling and genomic testing education undergo blood or saliva collection provide previously collected tissue sample and have medical records reviewed on study Patients and healthcare providers receive results of any genetic variants found on testing
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2024-04855 | REGISTRY | None | None |
| 24-000609 | OTHER | None | None |